TL;DR: A 2026 rat study in Psychopharmacology found that THC exposure during late adolescence left adult animals with elevated anxiety-like behavior and impaired object-recognition and spatial-memory performance after a drug-free recovery period. Key Findings Adolescent THC exposure produced lasting anxiety-like behavior in adulthood: Rats given THC (5 mg/kg/day) from postnatal day 42 to 62 (late …
TL;DR: A 2026 medRxiv preprint on schizophrenia reported that illness insight tracked with resting-state functional MRI (fMRI) flexibility, a measure of how dynamically brain regions reconfigure their connectivity, and that these brain-dynamics patterns aligned with dopamine D2 and serotonin 5-HT2A receptor maps after accounting for antipsychotic receptor occupancy. Key Findings Two insight subtypes: Clinical clustering …
TL;DR: A 2026 exploratory study in Nature Communications found that a first 25 mg psilocybin dose in 28 psychedelic-naive adults increased electroencephalography (EEG), a scalp recording of brain electrical activity, entropy during the acute session and that entropy predicted one-month well-being change. Key Findings 28 psychedelic-naive adults: Participants received 1 mg psilocybin as a low-dose …
TL;DR: A 2026 study in Brain, Behavior, & Immunity – Health found that depression symptoms, alcohol use, and alcohol use disorder (AUD) symptoms were not associated with C-reactive protein (CRP), a blood inflammation marker, or a pro-inflammatory cytokine index in 972 community adults, and twin analyses suggested familial confounding explained several cytokine-AUD links. Key Findings …
TL;DR: A 2026 study in Nature Neuroscience from Baylor College of Medicine showed that boosting Sox9, a transcription factor that regulates aging astrocytes, improved astrocytes’ ability to clear amyloid plaques in Alzheimer’s mouse models and preserved cognitive function — pointing to a treatment strategy that targets the brain’s own support cells rather than directly attacking …
Gabapentin Plus Hegu Embedding Improved Post-Herpetic Neuralgia TL;DR: Adding weekly Hegu-point catgut embedding to gabapentin cut post-herpetic neuralgia pain and sleep disruption more sharply, raising response from 80.0% to 92.4%. Key Findings 210 randomized PHN patients: Adults aged 40 to 70 with pain lasting at least 3 months were randomized 1:1 to gabapentin alone or …
Esketamine Lost the Cost-Effectiveness Race in Hong Kong TL;DR: A 5-year Hong Kong model found esketamine plus an antidepressant bought only a small quality-adjusted survival gain at US$29,061 per patient, leaving it behind cheaper third-line options like combination therapy. Key Findings Seven third-line strategies modeled: A Markov cohort model followed adults with treatment-resistant depression in …
Cannabinoids Had Weak Evidence for Mental Disorders TL;DR: A Lancet Psychiatry review of randomized trials found little support for routine cannabinoid treatment in common mental disorders, despite possible weak signals in a few narrower conditions. Key Findings 54 randomized controlled trials were reviewed: The analysis covered 2,477 participants across mental disorders and substance-use disorders. Routine …
TL;DR: A 2026 randomized trial in The British Journal of Psychiatry found 6 ketamine infusions improved severe treatment-resistant depression, but curated music added no measurable benefit; higher mystical-experience scores still predicted the next session’s depression outcome. Key Findings MADRS fell 11.8 points by week 4: Scores dropped from 31.5 to 19.7 (d = 1.2, p …
How Gene Therapy Mimicked Morphine for Chronic Pain TL;DR: A Nature study identified opioid-sensitive neurons in the anterior cingulate cortex and used a synthetic mu-opioid receptor promoter to silence them, producing morphine-like relief of chronic pain unpleasantness in mice without using a systemic opioid drug. Key Findings 700-μm nociceptive hotspot: The authors mapped a narrow …
